New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection

View source ↗

Summary

EMA announces approval of a new medicine to protect babies and infants from respiratory syncytial virus (RSV) infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection in Babies and Infants